Xpert® Hemorrhagic Fever on the GeneXpert® Edge X System

NCT07370454 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 408

Last updated 2026-01-27

No results posted yet for this study

Summary

A multi-site observation study that was conducted a geographically diverse sites across the United States

Conditions

  • Hemorrhagic Fever

Interventions

DIAGNOSTIC_TEST

Xpert Hemorrhagic Fever test

Detection and identification of RNA from multiple viruses from whole blood specimens

Sponsors & Collaborators

  • Cepheid

    lead INDUSTRY

Eligibility

Min Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-01-13
Primary Completion
2025-04-29
Completion
2025-10-03
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07370454 on ClinicalTrials.gov